Moderna's shares soared after the company said its potential vaccine to prevent Covid-19 produced a "robust" immune response in all 45 patients in its early stage human trial, according to newly released data published Tuesday evening in the peer-reviewed New England Journal of Medicine.Moderna's stock rose more than 16% in after-hours trading on the news. All…
Moderna Inc (NASDAQ: MRN) shares are surging above the $70 level for the first time since late May following sell-side commentary on its coronavirus vaccine program. The Moderna Analyst: Jefferies analyst Michael Yee initiated coverage of Moderna with a Buy rating and $90 price target. The Moderna Thesis: There is good probability the vaccine will work…
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/moderna-stock-jumps-as-analyst-expects-the-fda-to-approve-its-covid-19-vaccine-51594653061 July 13, 2020 11:11 am ET Order Reprints Print Article Shares of Moderna are up 239% so far this year, and the biotech company, which has no approved drugs, has a…
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New YorkGENEVA (Reuters) - AstraZeneca's experimental COVID-19 vaccine is probably the world's leading candidate and most advanced in terms of development, the World Health Organization's (WHO) chief scientist said on Friday.The British drugmaker has…
Moderna said Thursday that starting in 2021, it could manufacture "possibly up to 1 billion doses per year" of its experimental coronavirus vaccine with the help of a contract manufacturer.Yes, but: 1 billion vaccine doses may sound like a lot, but government and public health leaders would inevitably still have to make hard choices about…
(Maria Fabrizio for WPLN and KFF Health News) Jael Samano’s recent move from Illinois to Wisconsin after college changed a lot of things in her life. It brought a new job as an environmental consultant and a new housing situation — living on her own for the first time. Those were expected changes. But it
Two weeks ago, the Make America Healthy Again movement had its first real test at the ballot box, and it failed. Political scientists Robert Brehm and Matt Motta, writing in The Conversation, count more than half of the 24 candidates endorsed by MAHA Action among the losers. STAT counted at least eleven MAHA-aligned defeats, including Senator Roger
Early in her election-night victory speech, Democrat Keisha Lance Bottoms, Georgia’s next governor, alluded to one of her main campaign promises: granting more low-income adults access to government health insurance. “This win is for the caregiver who can’t afford healthcare and needs Georgia to finally expand Medicaid,” she told a crowd of cheering supporters. The